Prognosis and prognostic factors of papillary thyroid carcinoma in patients under 20 years

被引:43
作者
Ito, Yasuhiro [1 ]
Kihara, Minoru
Takamura, Yuuki
Kobayashi, Kaoru
Miya, Akihiro
Hirokawa, Mitsuyoshi [2 ]
Miyauchi, Akira
机构
[1] Kuma Hosp, Dept Surg, Chuo Ku, Kobe, Hyogo 6500011, Japan
[2] Kuma Hosp, Dept Pathol, Kobe, Hyogo 6500011, Japan
关键词
Papillary thyroid carcinoma; Prognosis; Age; ONE INSTITUTION; BRAF MUTATION; FOLLOW-UP; CHILDREN; CANCER; ADOLESCENTS; RISK; REARRANGEMENTS; FEATURES; SYSTEM;
D O I
10.1507/endocrj.EJ12-0086
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Age is an important prognostic factor of papillary thyroid carcinoma (PTC). In this study, we investigated the prognosis and prognostic factors of PTC in patients younger than 20 years. We enrolled 110 patients who underwent initial surgery at Kuma Hospital between 1987 and 2008. Tumor size > 4 cm, metastatic node >= 3 cm, and significant extrathyroid extension were more frequently detected in 8 patients with distant metastasis at diagnosis than in 102 patients without distant metastasis. Ten- and 20-year lymph node recurrence-free survival (LN-RFS) and distant recurrence-free survival (DRFS) rates were 84 and 80%, and 95 and 89%, respectively. Metastatic node >= 3 cm, age <= 16 years, tumor size > 4 cm, and male gender affected LN-RFS, and the former two had an independent prognostic value in multivariate analysis. Metastastic node >= 3 cm, significant extrathyroid extension, age <= 16 years, tumor size > 4 cm, and a male gender predicted a poor DRFS, and the former two were independent prognostic factors. To date, only 2 patients have died of PTC. These findings suggest that, in the subset of PTC patients younger than 20 years, metastatic node >= 3 cm, significant extension, and age <= 16 were important signs of aggressiveness of carcinoma, and careful treatment is necessary for patients with these characteristics, although the cause-specific survival was excellent.
引用
收藏
页码:539 / 545
页数:7
相关论文
共 42 条
[1]  
Bongarzone I, 1998, CLIN CANCER RES, V4, P223
[2]   Predictive factors for recurrence from a series of 74 children and adolescents with differentiated thyroid cancer [J].
Borson-Chazot, F ;
Causeret, S ;
Lifante, JC ;
Augros, M ;
Berger, N ;
Peix, JL .
WORLD JOURNAL OF SURGERY, 2004, 28 (11) :1088-1092
[3]  
CADY B, 1988, SURGERY, V104, P947
[4]  
CECCARELLI C, 1988, SURGERY, V104, P1143
[5]   Ret and trk proto-oncogene activation in thyroid papillary carcinomas in French patients from the Champagne-Ardenne region [J].
Delvincourt, C ;
Patey, M ;
Flament, JB ;
Suarez, HG ;
Larbre, H ;
Jardillier, JC ;
Delisle, MJ .
CLINICAL BIOCHEMISTRY, 1996, 29 (03) :267-271
[6]  
Dottorini ME, 1997, J NUCL MED, V38, P669
[7]  
Enomoto Y, 2012, WORLD J SUR IN PRESS
[8]   THYROID-CANCER IN CHILDREN AND ADOLESCENTS [J].
FASSINA, AS ;
RUPOLO, M ;
PELIZZO, MR ;
CASARA, D .
TUMORI, 1994, 80 (04) :257-262
[9]   The ret/PTC mutations are common in sporadic papillary thyroid carcinoma of children and young adults [J].
Fenton, CL ;
Lukes, Y ;
Nicholson, D ;
Dinauer, CA ;
Francis, GL ;
Tuttle, RM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (03) :1170-1175
[10]   Long-Term Outcome in 215 Children and Adolescents with Papillary Thyroid Cancer Treated During 1940 Through 2008 [J].
Hay, Ian D. ;
Gonzalez-Losada, Tomas ;
Reinalda, Megan S. ;
Honetschlager, Jennifer A. ;
Richards, Melanie L. ;
Thompson, Geoffrey B. .
WORLD JOURNAL OF SURGERY, 2010, 34 (06) :1192-1202